WORLD Uruguayan president gets first jab of Sinovac vaccine

WORLD

Uruguayan president gets first jab of Sinovac vaccine

Xinhua

13:32, March 30, 2021

Workers unload vaccines from Chinese pharmaceutical firm Sinovac on its arrival in Montevideo, Uruguay, March 16, 2021. (Photo: Nicolas Celaya/Xinhua)

MONTEVIDEO, March 29 (Xinhua) -- Uruguayan President Luis Lacalle Pou on Monday got his first dose of the CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac against COVID-19.

Speaking to reporters after getting vaccinated at the Maciel public hospital in Montevideo, Lacalle Pou thanked the "professionalism, humanism and disposition of the technical and medical teams, who are on the frontlines of vaccinating."

Photo: Xinhua

The president had announced before the start of the vaccination campaign which began on March 1 that he would be vaccinated when it was the turn of his age group.

The vaccination campaign targets those aged between 50 to 70 and over 80, and healthcare workers, education workers and members of the security forces, while during the Holy Week that started on Monday and will last until Saturday, all citizens over 18 years old are allowed to get inoculated.

Lacalle Pou acknowledged Uruguay is going through a "difficult" time, with an increase in COVID-19 cases "putting pressure on the last barrier, which are the ICUs (Intensive Care Units)."

Less than a month into the immunization drive, Uruguay has vaccinated more than 530,000 people, which is close to 15 percent of its population.

Since March 13, 2020, the South American country has registered 99,584 cases of COVID-19 and 928 deaths from the disease.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue